Treatment News : New Rapid Test for Acute HIV Is Now Available

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » October 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

October 30, 2013

New Rapid Test for Acute HIV Is Now Available

A new rapid test that can detect both HIV-1 and HIV-2 antibodies as well as a key antigen that indicates a recent infection with HIV-1 is now available for use in health care settings. The U.S. Food and Drug Administration approved the test, called the Alere Determine HIV-1/2 Ag/Ab Combo assay, in August. After taking blood from a finger prick, the test produces results in 20 minutes and has an accuracy exceeding 99 percent.

“We’re excited to announce the availability of the only fourth generation rapid test that can identify HIV infections in individuals earlier than ever before at the point of care by detecting the free HIV-1 p24 antigen,” Joe Medeiros, an Alere spokesperson, said in a release. “The availability of the Alere Determine Combo test will contribute measurably to public health by helping HIV-positive individuals to become aware of their HIV status earlier, thereby potentially reducing HIV transmission. Earlier diagnosis can also allow effective treatment to be started without delay.” 

The test is now available to all health care facilities and labs that have a license to conduct tests of “moderate complexity” through the U.S. Centers for Medicare and Medicaid Services’ Clinical Laboratory Improvement Amendments program. Pending the results of ongoing ease of use, safety and accuracy studies of the test, Alere intends to submit an application by the year’s end to the FDA for a CLIA waiver so that the test can be used more widely in both doctor’s offices and other outreach settings.

To read a release on the new test, click here.

Search: HIV test, antibodies, HIV-1, HIV-2, Alere, U.S. Food and Drug Administration, accuracy, p24 antigen, Joe Medeiros, Alere Determine HIV-1/2 Ag/Ab Combo, Clinical Laboratory Improvement Amendments, CLIA.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]


Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
Starting Treatment
Search for the Cure
POZ Stories
POZ TV
Read the Blogs
Visit the Forums
Women
African American
Latino
Providers
Job Listings
Events Calendar


    chipper52
    Palm Springs
    California


    koffeeboss
    Tucson
    Arizona


    Fred9774
    Brooklyn
    New York


    jacob2608
    Panama City Beach
    Florida
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Do you enjoy books with HIV-positive characters?
Yes
No

Survey
Mind Matters

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.